MERIDIAN BIOSCIENCE INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Meridian Bioscience Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q4 2022.
  • Meridian Bioscience Inc Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2022 was $6.04M, a 11.2% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $6.04M +$610K +11.2% Dec 31, 2022 10-Q 2023-02-09
Q3 2022 $5.85M +$64K +1.11% Sep 30, 2022 10-Q 2023-02-09
Q2 2022 $6.68M +$296K +4.64% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $7.52M +$1.22M +19.4% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $5.43M -$782K -12.6% Dec 31, 2021 10-Q 2022-02-04
Q3 2021 $5.79M -$550K -8.68% Sep 30, 2021 10-K 2022-11-22
Q2 2021 $6.38M -$88K -1.36% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $6.3M +$942K +17.6% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $6.21M +$172K +2.85% Dec 31, 2020 10-Q 2021-02-05
Q3 2020 $6.34M Sep 30, 2020 10-K 2021-11-23
Q2 2020 $6.47M Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $5.36M Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $6.04M Dec 31, 2019 10-Q 2020-02-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.